Citation Impact
Citing Papers
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
Chemistry, pharmacology and pharmacokinetics of N,N′,N′′ -triethylenethiophosphoramide (ThioTEPA)
2000
Disruption of the transcription factor recombination signal‐binding protein‐Jκ (RBP‐J) leads to veno‐occlusive disease and interfered liver regeneration in mice†
2008
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Development of a rapid and specific assay for detection of busulfan in human plasma by high‐performance liquid chromatography/electrospray ionization tandem mass spectrometry
2005
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Nocardiosis: Updated Clinical Review and Experience at a Tertiary Center
2010 Standout
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation
2004
Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease
2010 StandoutNobel
Vascular disorders of the liver # †
2008 Standout
Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: Incidence, risk factors, and outcome
1999
Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens
2001
Portal hypertensive bleeding in cirrhosis
2016 Standout
Pharmacokinetics of Once-Daily IV Busulfan as Part of Pretransplantation Preparative Regimens: A Comparison with an Every 6-Hour Dosing Schedule
2007
Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation
2000
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation
2006
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Pulmonary Complications in Adult Blood and Marrow Transplant Recipients
2005
Discordant detection of human cytomegalovirus DNA from peripheral blood mononuclear cells, granulocytes and plasma: correlation to viremia and HCMV infection
1998
Hematopoietic Stem-Cell Transplantation
2006 Standout
Porous metal–organic-framework nanoscale carriers as a potential platform for drug delivery and imaging
2009 Standout
Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: Decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality
2002
Analysis of anticancer drugs: A review
2011 Standout
the Role of Transjugular Intrahepatic Portosystemic Shunt (Tips) in the Management of Portal Hypertension: Update 2009
2009
Tacrolimus
1997
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Two Opposing Roles of RBP-J in Notch Signaling
2010 StandoutNobel
CLINICAL UTILITY OF QUANTITATIVE CYTOMEGALOVIRUS VIRAL LOAD DETERMINATION FOR PREDICTING CYTOMEGALOVIRUS DISEASE IN LIVER TRANSPLANT RECIPIENTS1
1999
The efficacy and safety of comfrey
2000
Serum Thrombopoietin Levels in Patients With Chronic Hepatitis and Liver Cirrhosis
1999
The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation
2000
Systematic Review of Controlled Clinical Trials on the Use of Ursodeoxycholic Acid for the Prevention of Hepatic Veno-occlusive Disease in Hematopoietic Stem Cell Transplantation
2007
Intravenous busulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation: Myeloablation with reduced toxicity
2003
Quantification of Busulfan in Saliva and Plasma in Haematopoietic Stem Cell Transplantation in Children
2006
A limited sampling strategy for pharmacokinetic directed therapy with intravenous busulfan
2002
Veno-Occlusive Disease of the Liver after High-Dose Cytoreductive Therapy with Busulfan and Melphalan for Autologous Blood Stem Cell Transplantation in Multiple Myeloma Patients
2007
Relationship of tacrolimus whole blood levels to efficacy and safety outcomes after unrelated donor marrow transplantation
1999
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS
2004
Tacrolimus
2000
VENO-OCCLUSIVE DISEASE OF THE LIVER
1955
Comparison of Quantitative and Qualitative PCR Assays for Cytomegalovirus DNA in Plasma
2001
Pyrrolizidine Alkaloids—Genotoxicity, Metabolism Enzymes, Metabolic Activation, and Mechanisms
2004 Standout
Electrochemiluminescence (ECL)
2004 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants
2003
Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Hematologic Malignancies After Dose-Escalated Treosulfan/Fludarabine Conditioning
2010
Busulfan systemic exposure after oral administration of extemporeanously prepared high-dose busulfan capsules
2009
Quantitation of Cytomegalovirus: Methodologic Aspects and Clinical Applications
1998
Electrogenerated Chemiluminescence and Its Biorelated Applications
2008 Standout
Metal–Organic Frameworks in Biomedicine
2011 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
A Highly Sensitive Assay for Detection and Quantitation of Human Cytomegalovirus DNA in Serum and Plasma by PCR and Electrochemiluminescence
1999
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Works of S M Devine being referenced
Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive care.
1996
Pulmonary Nocardia and Aspergillus co‐infection in a patient with chronic graft‐versus‐host disease
2007
Transjugular Intrahepatic Portosystemic Shunt for the Management of Severe Venoocclusive Disease Following Bone Marrow Transplantation
1996
FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation.
1995
Early detection of human cytomegalovirus viremia in bone marrow transplant recipients by DNA amplification
1995
Association of busulfan area under the curve with veno-occlusive disease following BMT.
1996
Bronchiolitis obliterans organizing pneumonia as a complication of allogeneic bone marrow transplantation.
1992